Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Hematologic Neoplasms 1Cardiotoxicity 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Razoxane 4Doxorubicin 4Dexrazoxane 4Vincristine 3Etoposide 3Radiotherapy 2Prednisone 2Methotrexate 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Bleomycin 2hydrocortisone hemisuccinate 1Watchful Waiting 1Trastuzumab 1Proton Therapy 1Observation 1Mercaptopurine 1Leucovorin 1Ifosfamide 1Hydrocortisone 1Enalapril 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Carvedilol 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Cardiotoxicity × Carvedilol × Clear all
NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

SWOG Cancer Research Network

Phase 3 Recruiting
491 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡